Clinical Scorecard: Surgical Approaches to Intracerebral Hemorrhage: Emerging Evidence and Evolving Perspectives

At a Glance

Key Highlights

• ICH has a high 1-month fatality rate (~35–40%) with limited effective interventions for long-term neurological outcome.
• Open craniotomy has not shown significant benefit over medical management in large RCTs, but limitations exist including patient selection and crossover.
• Minimally invasive surgical techniques, such as MIPS and catheter-based thrombolysis, reduce hematoma volume but have not consistently improved functional outcomes.

Guideline-Based Recommendations

Diagnosis

• Use advanced neuroimaging including diffusion tensor imaging (DTI) tractography for surgical planning in minimally invasive approaches.

Management

• Consider early minimally invasive hematoma evacuation (e.g., MIPS) for selected patients with lobar or anterior basal ganglia hemorrhages.
• Decompressive craniectomy may be considered for large basal ganglia hemorrhages without hematoma evacuation in severe cases.
• Best medical management remains standard for many patients, with surgery reserved for specific indications.

Monitoring & Follow-up

• Monitor neurological status closely to identify patients at imminent risk of cerebral herniation who may benefit from surgery.
• Assess hematoma volume and functional outcomes longitudinally post-intervention.

Risks

• Surgical risks include procedure-related complications, incomplete clot evacuation, seizures, infection, and cerebral edema.
• Delayed intervention and patient selection challenges may limit surgical efficacy.

Patient & Prescribing Data

Adults with spontaneous supratentorial ICH, moderate-to-severe hemorrhage volume (30–80 mL), including lobar and basal ganglia locations

Minimally invasive surgery achieves substantial hematoma volume reduction (~69%) but has not demonstrated statistically significant improvement in 12-month functional independence compared to conservative care.

Clinical Best Practices

• Utilize neuronavigation and advanced imaging to plan minimally invasive surgical trajectories that avoid eloquent cortex and white matter tracts.
• Employ minimally invasive trans-sulcal parafascicular approaches (MIPS) to reduce iatrogenic injury and improve clot evacuation efficiency.
• Select patients carefully based on hemorrhage location, volume, and neurological status to optimize surgical benefit.
• Consider decompressive craniectomy without hematoma evacuation in severe deep supratentorial ICH cases at risk of herniation.
• Continue best medical management and reserve surgery for patients with specific indications or deterioration.

References

• ENRICH trial on minimally invasive hematoma evacuation
• MISTIE III trial on minimally invasive surgery with thrombolysis
• SWITCH trial on decompressive craniectomy for ICH